ASP Isotopes (NASDAQ:ASPI) Sets New 52-Week High - Here's Why

Key Points

• ASP Isotopes shares reached a new 52-week high at $11.86 during trading, reflecting strong investor interest with a trading volume of 4.3 million shares.
• The company reported a loss of $1.03 earnings per share for the last quarter, significantly missing the analyst consensus estimate of a loss of $0.11.
• Insider trading activity includes a director selling 75,000 shares and the CEO selling 81,077 shares, collectively amounting to over $1.3 million in shares sold in recent transactions.

Shares of ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) reached a new 52-week high during mid-day trading on Tuesday . The company traded as high as $11.86 and last traded at $11.45, with a volume of 4319567 shares trading hands. The stock had previously closed at $11.22.

Analyst Ratings Changes

Separately, Canaccord Genuity Group reiterated a "buy" rating and issued a $11.00 target price on shares of ASP Isotopes in a research note on Wednesday, September 17th. Two research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, ASP Isotopes currently has a consensus rating of "Buy" and a consensus price target of $7.75.

ASP Isotopes Trading Up 2.0%

The company has a fifty day moving average price of $9.42 and a 200-day moving average price of $7.40. The company has a current ratio of 14.72, a quick ratio of 14.56 and a debt-to-equity ratio of 3.53. The firm has a market capitalization of $1.05 billion, a price-to-earnings ratio of -18.75 and a beta of 3.36.

ASP Isotopes (NASDAQ:ASPI - Get Free Report) last posted its earnings results on Thursday, August 14th. The company reported ($1.03) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($0.92). The company had revenue of $1.20 million during the quarter, compared to analyst estimates of $1.60 million. ASP Isotopes had a negative return on equity of 239.22% and a negative net margin of 2,181.62%. On average, equities research analysts predict that ASP Isotopes Inc. will post -0.24 EPS for the current year.

Insider Buying and Selling

In related news, Director Duncan Moore sold 75,000 shares of the firm's stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $9.28, for a total transaction of $696,000.00. Following the completion of the transaction, the director owned 994,553 shares in the company, valued at $9,229,451.84. This trade represents a 7.01% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Paul Elliot Mann sold 81,077 shares of the business's stock in a transaction on Tuesday, September 9th. The shares were sold at an average price of $8.39, for a total transaction of $680,236.03. Following the completion of the sale, the chief executive officer owned 8,084,191 shares in the company, valued at $67,826,362.49. This represents a 0.99% decrease in their position. The disclosure for this sale can be found here. Insiders sold 245,591 shares of company stock worth $2,139,790 in the last 90 days. 21.40% of the stock is owned by company insiders.

Institutional Trading of ASP Isotopes

Large investors have recently made changes to their positions in the business. BNP Paribas Financial Markets bought a new stake in shares of ASP Isotopes during the fourth quarter worth $34,000. Ameritas Investment Partners Inc. grew its holdings in shares of ASP Isotopes by 41.2% during the second quarter. Ameritas Investment Partners Inc. now owns 5,483 shares of the company's stock worth $40,000 after purchasing an additional 1,600 shares during the last quarter. SBI Securities Co. Ltd. lifted its stake in shares of ASP Isotopes by 84.8% during the first quarter. SBI Securities Co. Ltd. now owns 9,370 shares of the company's stock valued at $44,000 after acquiring an additional 4,299 shares during the period. Millennium Management LLC acquired a new position in shares of ASP Isotopes during the fourth quarter valued at $55,000. Finally, Fortitude Advisory Group L.L.C. acquired a new position in shares of ASP Isotopes during the first quarter valued at $64,000. Institutional investors own 16.80% of the company's stock.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.